BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Gene Logic Inc. genetic targets for drug
development in heart
failure and two
undisclosed diseases
$75M drug
development
ageement
Copyright ©2006 AHC Media ® 327
6/97
Geron Corp. Geron's human
telomerase reverse
transcriptase
technology
research agreement 7/04
Lederle
Ziac (bisoprolol and hct) joint marketing 12/92
Laboratories
Locus
Pharmaceuticals
Inc.
treatment for diabetes
agreement
research agreement 7/04
MGI Pharma Inc. Didronel IV infusion MGI bought
exclusive rights to
IV form for oncology
market (P&G to
retain rights to oral
Oxford Molecular
Group plc.
Oxford's RS3 Discovery
and RS3 Discovery
High-Throughput
Screening research
information
management software
in P&G's discovery
research programs
Quidel Corp. Quidel's QuickVue 1step
H. pylori test and
P&G's Helidac therapy
Regeneron
Pharmaceuticals
Inc.
treatments for muscle
diseases and disorders
Sanofi-Aventis Actonel (risedronate
sodium tablets);
includes option for P&G
to acquire oral health
care brands from
sanofi-aventis
Synergen Inc. collagenase inhibitor for
treatment of periodontal
disease
TheraTech Inc. estradiol and
estradiol/progestin
TheraTech Inc. transdermal
testosterone and
combination
estradiol/testosterone
hormone replacement
patches for women
1/90
form)
licensing agreement 5/98
one-year,
renewable
copromotion
agreement
drug discovery
collaboration
(12/96), P&G made
equity investment
by purchasing
$10M of Regeneron
stock (3/97),
expanded to include
obesity related to
Type II diabetes
(9/97), P&G made
$5M milestone
payment
continuation of R&D
and
commercialization
agreement
development
agreement
worldwide
development and
distribution
agreement
excluding parts of
Asia
development
agreement--P&G
will fund all
development,
TheraTech gets
R&D payments and
1/97
7/98
10/04
3/86
3/95
12/97